SLBT
SL Science Holding Ltd
There isn't enough reported data to score SLBT yet.
SLBT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate SLBT's fundamentals.
SLBT PE Valuation
SLBT has no meaningful PE right now: it lost money over the past year.
SLBT Forward outlook
There aren't enough analyst estimates for SLBT to show an outlook.
SLBT Earnings Per Share
SLBT Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -142% | N/A |
| Q1 2025 | -142% | N/A |
SLBT Free Cash Flow
SLBT Net Leverage
SLBT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SLBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 6.8 | Oversold |
SLBT's weekly RSI is 44 (neutral) and its Stochastic is 7 (oversold).
SLBT PE vs Healthcare Sector
SLBT has no meaningful PE right now: it lost money over the past year.
SLBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.28 | 41% below |
| 20 week MA | $2.42 | 69% below |
SLBT is in a downtrend: it's below all two of its weekly moving averages, and 69% below its 20-week average.
SLBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $8.75 | $0.76 | -91% |
It's down 91% so far in 2026.